One-year Data from ENDEAVOR, a Phase 1b Trial of Delandistrogene Moxeparvovec (SRP-9001) in Patients with Duchenne Muscular Dystrophy (DMD)Craig Zaidman,Crystal Proud,Craig McDonald,Stefanie Mason,Maitea Guridi,Shufang Wang,Carol Reid, Eddie Darton,Christoph Wandel,Sarah Lewis,Jyoti Malhotra,Danielle Griffin,Rachael Potter,Louise Rodino-Klapac,Jerry MendellNEUROLOGY(2023)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要